See also this year's filing and all EDGAR filings for this company.
PDF Report 0001253689_2019_Crescent_Biopharma_INC.pdf
Logs
| warning | The stock_price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001253689, Crescent Biopharma INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 212,269,119 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 957,226 |
| 3 | remainder_Assets | 1,612,927 |
| 4 | LiabilitiesCurrent | 8,763,154 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 611,623 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 11,945,356 |
| 9 | ResearchAndDevelopmentExpense | 45,759,946 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 16,131,080 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 214,839,272 |
| 1 | Liabilities | 9,374,777 |
| 2 | Expenses | 57,705,302 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 205,464,495 |
| 5 | NetIncome | -41,574,222 |
| 6 | ComprehensiveNetIncome | -41,574,222 |
| 7 | BaseVar | 149,025,216 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.62 |
| 9 | EconomicCapitalRatio | 4.12 |